RIYADH, Saudi Arabia, March 20, 2025 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) has reported a significant increase in the number of targeted mutations analysed. The latest data reveal that the number of analyzed mutations has increased from 3,969 cases in 2023 to 5,514 in 2024, representing a 38.93% growth. This surge reflects the increasing reliance on genetic diagnostics for identifying hereditary diseases, guiding cancer treatments, and tailoring therapies to individual patients.
Targeted mutation analysis is a crucial component of modern genomic medicine, enabling the identification of specific genetic variations that contribute to disease development. Unlike whole-genome sequencing, which examines an individual’s entire genetic code, this approach relies on known…